OncoSenX

Business Data, Corporate Office and Headquarter Address

About

OncoSenX is Drug Discovery in United States that focus on plasmid DNA business. Founded in 2017. They cover business area such as developer, transient gene therapy, cancer, few side effect, apoptosis, plasmid DNA, a novel proteo-lipid vehicle, their transcriptional activity, doctor, medical care professional.

Business Type

Drug Discovery

Country

United States

Founded

2017
( 7 years old in 2024 )

Company Focus

Plasmid DNA

Website

-

Corporate Office and Headquarter Office address:

701 Fifth Avenue
Suite 4200
Seattle, WA 98104
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developertransient gene therapycancerfew side effectapoptosisplasmid DNAa novel proteo-lipid vehicletheir transcriptional activitydoctormedical care professional

* We use standard office opening hours in near OncoSenX's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

OncoSenX Frequently Asked Questions

What or who is OncoSenX?

OncoSenX is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), OncoSenX business is focusing on Plasmid DNA.

Where is OncoSenX headquarter and corporate office address?

OncoSenX headquarter office and corporate office address is located in 701 Fifth Avenue Suite 4200 Seattle, WA 98104 United States.

Where is OncoSenX country origins?

OncoSenX was founded in United States.

What is Plasmid DNA business focus on?

In 2024, OncoSenX is currently focus on plasmid DNA sector.

Plasmid DNA Business Interest from Google Trend

Above is snippet of Google Trends for "plasmid DNA" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with OncoSenX, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.